Alterations of 5-Hydroxymethylcytosine in Human Cancers

Christopher J. Mariani(University of Chicago), Lucy A. Godley(University of Chicago), Jozef Madžo(University of Chicago), Ali E. Yesilkanal(University of Chicago), Erika L. Moen(Dartmouth College)

Cancers

June 25, 2013

10.3390/cancers5030786

Cited by 53

Related Papers

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

|Blood|2022|3.1k

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

|Blood|2022|2.8k

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

|Cancer Cell|2010|2.7k

Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host

|Nature|2018|405

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

|Blood|2011|402